Loading...
INSIGHT FLU005: An Anti–Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study
Hemagglutination inhibition (HAI) antibody responses to anti–influenza virus hyperimmune intravenous immunoglobulin (hIVIG) were characterized. Thirty-one patients with influenza during the 2013–2014 season were randomly assigned to receive 0.25 g/kg of hIVIG (n = 16) or placebo (n = 15). For hIVIG...
Na minha lista:
| Udgivet i: | J Infect Dis |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4721910/ https://ncbi.nlm.nih.gov/pubmed/26374911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiv453 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|